Rising energy costs and geopolitical instability pressured US indices, with the Dow falling 0.83% as investors braced for potential interest rate hikes and trade-related economic headwinds.
WTI crude oil prices have surged over 1% to a 3-month high, driven by supply concerns stemming from attacks on Saudi Arabian oil facilities and ongoing geopolitical conflict in the Strait of Hormuz. The tightening of global oil markets, exacerbated by the loss of millions of barrels per day from the Middle East and Russia, continues to push prices upward.
Prices are rising due to Houthi rebel attacks on Saudi oil infrastructure and ongoing tensions between the US and Iran, which have tightened global supply.
Amgen is down more than -7%, leading losses across major indices following a broader biotech selloff triggered by Novartis's recent clinical trial failure. The market sentiment for the sector has soured, causing significant declines in several pharmaceutical and biotech equities.
Amgen is falling as part of a broader biotech sector selloff triggered by a failed late-stage clinical trial by Novartis.
The Dow Jones Industrial Average is under significant pressure, falling -0.83% as broad market sentiment is dampened by geopolitical tensions and rising inflation concerns. The index is further weighed down by a sharp selloff in biotechnology stocks, including heavyweights like Amgen.
The index is declining due to a combination of rising crude oil prices, geopolitical tensions, and a broad selloff in the biotech sector.
The S&P 500 is down -0.34% as investors react to surging crude oil prices, which have reached a 3-month high and heightened expectations for sustained interest rate hikes. While gains in chipmakers and energy stocks have provided some support, broader market sentiment remains negative due to trade war concerns and weaker-than-expected Chinese economic data.
Rising crude oil prices are increasing inflation expectations, leading to concerns that central banks will maintain a hawkish interest rate policy.
The Nasdaq 100 is down -0.19%, reflecting a tug-of-war between a sharp selloff in software and biotech stocks and strong gains in the semiconductor sector. Despite the index-wide decline, chipmakers like Intel and Qualcomm have provided a buffer against deeper losses.
No, while software stocks are under pressure, chipmakers and AI-infrastructure stocks are moving higher, with the iShares Semiconductor ETF reaching a 2.5-week high.
US equity markets retreated on Monday as WTI crude oil prices climbed over 2% to a three-month high, fueling renewed inflation concerns. The Dow Jones Industrial Average led the decline, falling 0.83%, while the S&P 500 and Nasdaq 100 also posted losses amid escalating Middle East tensions and a broadening trade dispute between the US and Canada.
Markets are reacting to a surge in crude oil prices, which has heightened inflation expectations and increased the likelihood of further interest rate hikes by the Federal Reserve.